Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors

Pediatric Blood and Cancer

Volumn 61, Issue 8, 2014, Pages 1398-1402

  Dufour, Christelle ^a   Kieffer, Virginie ^a,b   Varlet, Pascale ^c   Raquin, Marie Anne ^a   Dhermain, Frederic ^a   Puget, Stephanie ^d   Valteau Couanet, Dominique ^a   Grill, Jacques ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Hospital National de Saint Maurice   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Childhood; High dose chemotherapy; Medulloblastoma

Indexed keywords

ANTICONVULSIVE AGENT; CARBOPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; TEMOZOLOMIDE; THIOTEPA;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; CRANIOSPINAL IRRADIATION; DIARRHEA; DRUG FEVER; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; EVENT FREE SURVIVAL; FEASIBILITY STUDY; FOLLOW UP; FULL SCALE INTELLECTUAL QUOTIENT EXAMINATION; GASTROINTESTINAL TOXICITY; HUMAN; INDUCTION CHEMOTHERAPY; INTELLIGENCE QUOTIENT; MEDULLOBLASTOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PINEAL BODY TUMOR; PRIORITY JOURNAL; SEIZURE; SEPTICEMIA; SKIN TOXICITY; SUPRATENTORIAL PRIMITIVE NEURO ECTODERMIC TUMOR; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE;

CHILDHOOD; HIGH-DOSE CHEMOTHERAPY; MEDULLOBLASTOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOGRAFTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDULLOBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 84901981679     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25009     Document Type: Article

References (25)

1. Gilbertson RJ. Medulloblastoma: Signalling a change in treatment. Lancet Oncol 2004; 5:209-218.
2. Hughes EN, Shillito J, Sallan SE, et al. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer 1988; 61:1992-1998.
3. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81:690-698.
4. Strother D, Ashley D, Kellie SJ, et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Results of a collaborative study. J Clin Oncol 2001; 19:2696-2704.
5. Verlooy J, Mosseri V, Bracard S, et al. Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. Eur J Cancer 2006; 42:3004-3014.
6. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17:832-845.
7. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 2004; 22:4881-4887.
8. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7:813-820.
9. Grill J, Dufour C, Kalifa C. High-dose chemotherapy in children with newly-diagnosed medulloblastoma. Lancet Oncolgy 2006; 7:787-789.
10. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007; 114:97-109.
11. Grill J, Lellouch-Tubiana A, Elouahdani S, et al. Preoperative chemotherapy in children with high-risk medulloblastomas: A feasibility study. J Neurosurg 2005; 103:312-318.
12. Riccardi R, Cefalo G, Ruggiero A, et al., editors. Antitumor activity of temozolomide in medulloblastoma-PNET. 12th international symposium on pediatric neuro-oncology; 2006; Nara, Japan.
13. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969; 93:1351-1359.
14. Zeltzer PM, Friedman HS, Norris DG, et al. Criteria and definitions for response and relapse in children with brain tumors. Cancer 1985; 56:1824-1826.
15. Sung KW, Lim do H, Son MH, et al. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma. Neuro Oncol 2013; 15:352-359.
16. Allen JC, Donahue B, DaRosso R, et al. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int J Radiat Oncol, Biol Phys 1996; 36:1155-1161.
17. Prados MD, Edwards MS, Chang SM, et al. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Results of a phase II study. Int J Radiat Oncol, Biol, Phys 1999; 43:279-285.
18. Gandola L, Massimino M, Cefalo G, et al. Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 2009; 27:566-571.
19. Jakacki R, Burger P, Zhou T, et al. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: A Children's Oncology Group Phase I/II Study. J Clin Oncol 2012; 30:2648-2653.
20. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol, Biol, Phys 1999; 45:137-145.
21. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J Clin Oncol 1998; 16:1723-1728.
22. Steen RG, Koury BSM, Granja CI, et al. Effect of ionizing radiation on the human brain: White matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol, Biol, Phys 2001; 49:79-91.
23. Steen RG, Spence D, Wu S, et al. Effect of therapeutic ionizing radiation on the human brain. Ann Neurol 2001; 50:787-795.
24. Kieffer-Renaux V, Viguier D, Raquin MA, et al. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer 2005; 45:814-819.
25. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 2001; 19:2302-2308.